Ask the Editor: UHPLC Particle Size Limitations
Q: The current advent of sub-2-?m particles has made ultrahigh-pressure liquid chromatography (UHPLC) available for routine laboratory use. What are the size limitations for particles? How small can they get before the advantages are lost? Would smaller particles require even greater pressures?"
The answer to the following question was provided by Roy Eksteen of Tosoh Bioscience (Montgomeryville, Pennsylvania).
An LCGC reader recently submitted the following question:
The current advent of sub-2-µm particles has made ultrahigh-pressure liquid chromatography (UHPLC) available for routine laboratory use. What are the size limitations for particles? How small can they get before the advantages are lost? Would smaller particles require even greater pressures?
The last part of the question is simple and that is where I will start. More pressure will be required when particle size is lowered, to the extent that a 50% reduction in particle size will lead to a fourfold increase in pressure when the same linear velocity is maintained through the packed bed. There is not an end to this relationship, although I am doubtful that it continues to hold at the atomic level.
With regards to the first part of the question, I am not aware of a theoretical limit to ever-higher efficiency with reducing particle size. After discussion with others more skilled in theoretical physics, I suggest that particle aggregation becomes more and more a problem when reducing particle size down to 1 µm and below, to the point that packing a stable and efficient column bed becomes practically impossible. I realize that the trouble with such an answer is that the problem of aggregation (or any nontheoretical limitation) leaves the door open for some future solution. I'll live with that.
Questions?
LCGC technical editor Steve Brown will answer your technical questions. Each month, one question will be selected to appear in this space, so we welcome your submissions. Please send all questions to the attention of "Ask the Editor" at lcgcedit@lcgcmag.com We look forward to hearing from you.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.
